Literature DB >> 26559863

A 90-Day Subchronic Toxicity Study of Submerged Mycelial Culture of Cordyceps cicadae (Ascomycetes) in Rats.

Yen-Lien Chen1, Shu-Hsing Yeh2, Ting-Wei Lin2, Chin-Chu Chen3, Chin-Shuh Chen1, Chia-Feng Kuo4.   

Abstract

Cordyceps cicadae is a parasitic fungus that hibernates inside a host (Cicada flammata Dist.) and then grows its fruiting body on the surface of the insect. The complete insect/fungus combination of C. cicadae has been widely applied in Chinese traditional medicine. Recent studies have demonstrated that the medicinal benefits of cultured mycelia are as effective as those found in the wild. However, toxicological information regarding the chronic consumption of C. cicadae mycelia culture is not available. This study was conducted to evaluate the possible toxicity arising from repeated exposure to freeze-dried submerged mycelial culture of C. cicadae for 90 days. A total of eighty 8-week-old Sprague-Dawley rats were divided into 4 groups (10 males and 10 females in each group). C. cicadae was administered daily to animals by gavage at doses of 0, 500, 1000, and 2000 mg/kg body weight for 90 days. No animal deaths occurred and no treatment-related clinical signs were observed during the study period. No statistical differences in body weight gain, relative organ weight, hematology, serum chemistry, and urinalysis were observed. Gross necropsy and histopathological findings indicated that there was no treatment-related abnormality. Based on the results, the no observed adverse effect level of C. cicadae whole broth is determined to be > 2000 mg/kg for male and female Sprague-Dawley rats. The results of this study provides support for the use of C. cicadae fermentation product as a safe agent in functional food.

Entities:  

Mesh:

Year:  2015        PMID: 26559863     DOI: 10.1615/intjmedmushrooms.v17.i8.70

Source DB:  PubMed          Journal:  Int J Med Mushrooms        ISSN: 1940-4344            Impact factor:   1.921


  6 in total

1.  Network Pharmacology-Based Exploration of the Therapeutic Mechanisms of Cordyceps cicadae in Renal Ischemia/Reperfusion.

Authors:  Jiajun Dong; Mingyang Cao; Hui Yu; Yang Dong; Conghui Han
Journal:  Ann Transplant       Date:  2022-09-30       Impact factor: 1.479

2.  Glucose-lowering and hypolipidemic activities of polysaccharides from Cordyceps taii in streptozotocin-induced diabetic mice.

Authors:  Ru-Ming Liu; Rong Dai; Yi Luo; Jian-Hui Xiao
Journal:  BMC Complement Altern Med       Date:  2019-08-23       Impact factor: 3.659

3.  Intraocular pressure-lowering effect of Cordyceps cicadae mycelia extract in a glaucoma rat model.

Authors:  Chi-Ting Horng; Ya-Lan Yang; Chin-Chu Chen; Yu-Syuan Huang; Chun Chen; Fu-An Chen
Journal:  Int J Med Sci       Date:  2021-01-01       Impact factor: 3.738

4.  Lowering the Intraocular Pressure in Rats and Rabbits by Cordyceps cicadae Extract and Its Active Compounds.

Authors:  Li-Ya Lee; Jui-Hsia Hsu; Hsin-I Fu; Chin-Chu Chen; Kwong-Chung Tung
Journal:  Molecules       Date:  2022-01-21       Impact factor: 4.411

Review 5.  Secondary metabolites (SMs) of Isaria cicadae and Isaria tenuipes.

Authors:  Xiaofeng Zhang; Qiongbo Hu; Qunfang Weng
Journal:  RSC Adv       Date:  2018-12-21       Impact factor: 4.036

6.  Cordyceps cicadae Mycelia Ameliorate Cisplatin-Induced Acute Kidney Injury by Suppressing the TLR4/NF-κB/MAPK and Activating the HO-1/Nrf2 and Sirt-1/AMPK Pathways in Mice.

Authors:  Jeng-Shyan Deng; Wen-Ping Jiang; Chin-Chu Chen; Li-Ya Lee; Pei-Ying Li; Wen-Chin Huang; Jung-Chun Liao; Hung-Yi Chen; Shyh-Shyun Huang; Guan-Jhong Huang
Journal:  Oxid Med Cell Longev       Date:  2020-02-06       Impact factor: 6.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.